Cargando…

Prevalence and Disability-Adjusted Life Year Rates of Asthma in China: Findings from the GBD Study 2019 of the G20

Background: The credible materials about the burden of asthma in China when compared to other countries in the group of twenty (G20) remain unavailable. Objectives and design: Following the popular analysis strategy used in the Global Burden of Disease Study, the age-, sex-, country-specific prevale...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Mingtao, Gan, Hui, Lin, Yilu, Lin, Runpei, Xue, Mingshan, Zhang, Teng, Cheng, Zhangkai J., Sun, Baoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690014/
https://www.ncbi.nlm.nih.gov/pubmed/36429381
http://dx.doi.org/10.3390/ijerph192214663
_version_ 1784836679806222336
author Liu, Mingtao
Gan, Hui
Lin, Yilu
Lin, Runpei
Xue, Mingshan
Zhang, Teng
Cheng, Zhangkai J.
Sun, Baoqing
author_facet Liu, Mingtao
Gan, Hui
Lin, Yilu
Lin, Runpei
Xue, Mingshan
Zhang, Teng
Cheng, Zhangkai J.
Sun, Baoqing
author_sort Liu, Mingtao
collection PubMed
description Background: The credible materials about the burden of asthma in China when compared to other countries in the group of twenty (G20) remain unavailable. Objectives and design: Following the popular analysis strategy used in the Global Burden of Disease Study, the age-, sex-, country-specific prevalence, and disability-adjusted life years (DALYs) of asthma in China were analyzed. Meanwhile, the comparison in trends between China and other countries in the G20 was also evaluated. Results: In 2019, asthma was the 8th leading cause of the DALYs’ burden of 369 diseases in China. From 1990 to 2019, the age-standardized prevalence and DALY rates of asthma in China decreased by 14% and 51%, respectively; further, the decline rate of DALYs was much higher than the global average (−51%: −43%). It is worth noting that the overall population age-standardized DALYs rate of asthma in China was the lowest in the G20 during 2019 (102.81, 95% UI: (72.30,147.42)/100,000). Moreover, the age-standardized asthma prevalence rate peaks in both childhood (178.14, 95% UI: (90.50, 329.01)/100,000) and the elderly (541.80, 95% UI: (397.79, 679.92)/100,000). Moreover, throughout the study, subjects in the 5 to 9 years old interval were a constant focus of our attention. Conclusions: The disease burden of asthma has varied greatly by gender and age over the past 30 years. In contrast to the increasing burden in most other G20 countries, the age-standardized prevalence rate of asthma shows a significant decreasing trend in China, however, the age-standardized DALYs rate shows a fluctuating change, and has even shown a rebound trend in recent years.
format Online
Article
Text
id pubmed-9690014
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96900142022-11-25 Prevalence and Disability-Adjusted Life Year Rates of Asthma in China: Findings from the GBD Study 2019 of the G20 Liu, Mingtao Gan, Hui Lin, Yilu Lin, Runpei Xue, Mingshan Zhang, Teng Cheng, Zhangkai J. Sun, Baoqing Int J Environ Res Public Health Article Background: The credible materials about the burden of asthma in China when compared to other countries in the group of twenty (G20) remain unavailable. Objectives and design: Following the popular analysis strategy used in the Global Burden of Disease Study, the age-, sex-, country-specific prevalence, and disability-adjusted life years (DALYs) of asthma in China were analyzed. Meanwhile, the comparison in trends between China and other countries in the G20 was also evaluated. Results: In 2019, asthma was the 8th leading cause of the DALYs’ burden of 369 diseases in China. From 1990 to 2019, the age-standardized prevalence and DALY rates of asthma in China decreased by 14% and 51%, respectively; further, the decline rate of DALYs was much higher than the global average (−51%: −43%). It is worth noting that the overall population age-standardized DALYs rate of asthma in China was the lowest in the G20 during 2019 (102.81, 95% UI: (72.30,147.42)/100,000). Moreover, the age-standardized asthma prevalence rate peaks in both childhood (178.14, 95% UI: (90.50, 329.01)/100,000) and the elderly (541.80, 95% UI: (397.79, 679.92)/100,000). Moreover, throughout the study, subjects in the 5 to 9 years old interval were a constant focus of our attention. Conclusions: The disease burden of asthma has varied greatly by gender and age over the past 30 years. In contrast to the increasing burden in most other G20 countries, the age-standardized prevalence rate of asthma shows a significant decreasing trend in China, however, the age-standardized DALYs rate shows a fluctuating change, and has even shown a rebound trend in recent years. MDPI 2022-11-08 /pmc/articles/PMC9690014/ /pubmed/36429381 http://dx.doi.org/10.3390/ijerph192214663 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Liu, Mingtao
Gan, Hui
Lin, Yilu
Lin, Runpei
Xue, Mingshan
Zhang, Teng
Cheng, Zhangkai J.
Sun, Baoqing
Prevalence and Disability-Adjusted Life Year Rates of Asthma in China: Findings from the GBD Study 2019 of the G20
title Prevalence and Disability-Adjusted Life Year Rates of Asthma in China: Findings from the GBD Study 2019 of the G20
title_full Prevalence and Disability-Adjusted Life Year Rates of Asthma in China: Findings from the GBD Study 2019 of the G20
title_fullStr Prevalence and Disability-Adjusted Life Year Rates of Asthma in China: Findings from the GBD Study 2019 of the G20
title_full_unstemmed Prevalence and Disability-Adjusted Life Year Rates of Asthma in China: Findings from the GBD Study 2019 of the G20
title_short Prevalence and Disability-Adjusted Life Year Rates of Asthma in China: Findings from the GBD Study 2019 of the G20
title_sort prevalence and disability-adjusted life year rates of asthma in china: findings from the gbd study 2019 of the g20
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690014/
https://www.ncbi.nlm.nih.gov/pubmed/36429381
http://dx.doi.org/10.3390/ijerph192214663
work_keys_str_mv AT liumingtao prevalenceanddisabilityadjustedlifeyearratesofasthmainchinafindingsfromthegbdstudy2019oftheg20
AT ganhui prevalenceanddisabilityadjustedlifeyearratesofasthmainchinafindingsfromthegbdstudy2019oftheg20
AT linyilu prevalenceanddisabilityadjustedlifeyearratesofasthmainchinafindingsfromthegbdstudy2019oftheg20
AT linrunpei prevalenceanddisabilityadjustedlifeyearratesofasthmainchinafindingsfromthegbdstudy2019oftheg20
AT xuemingshan prevalenceanddisabilityadjustedlifeyearratesofasthmainchinafindingsfromthegbdstudy2019oftheg20
AT zhangteng prevalenceanddisabilityadjustedlifeyearratesofasthmainchinafindingsfromthegbdstudy2019oftheg20
AT chengzhangkaij prevalenceanddisabilityadjustedlifeyearratesofasthmainchinafindingsfromthegbdstudy2019oftheg20
AT sunbaoqing prevalenceanddisabilityadjustedlifeyearratesofasthmainchinafindingsfromthegbdstudy2019oftheg20